Global Osteosarcoma Market report; provides a detailed analysis of the market from 2013 to 2023. The report provides comprehensive analysis for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2018 through 2023. Also, a five-year historic analysis is provided for these markets from 2013 to 2017 / 2018 (as per the data availability). Market data and analytics are derived from primary and secondary research.
An osteosarcoma (OS) is a cancerous tumor in a bone. Specifically, it is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin (and thus a sarcoma) and that exhibits osteoblastic differentiation and produces malignant osteoid. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in teenagers and young adults.
Osteosarcoma is the eighth-most common form of childhood cancer, comprising 2.4% of all malignancies in pediatric patients, and about 20% of all primary bone cancers. Incidence rates for osteosarcoma in U.S. patients under 20 years of age are estimated at 5.0 per million per year in the general population, with a slight variation between individuals of black, Hispanic, and white ethnicities (6.8, 6.5, and 4.6 per million per year, respectively). It is slightly more common in males (5.4 per million per year) than in females (4.0 per million per year).
The major manufacturers covered in this report: Pfizer, Spectrum Pharmaceuticals, Hikma Pharmaceuticals, Baxter, Isofol, Advaxis, Bellicum Pharmaceuticals, Novartis and Others
Avail Sample Copy before Purchase @:
Osteosarcoma Market Segmentation by product type
Osteosarcoma Market Segmentation by application
Hospital & Clinics
Cancer Research Institutes
Osteosarcoma Market segmented by Regions:
North America (United States, Canada, Mexico)
Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam)
Europe (Germany, France, UK, Italy, Russia, Rest of Europe)
Central & South America (Brazil, Rest of South America)
Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa, Other)
Special Offer: Get flat 15% discount on this report
Avail Discount on this @:
The research provides answers to the following key questions:
What will be the Osteosarcoma Market size and the growth rate in 2023?
What are the key factors driving the global Osteosarcoma Market?
Who are the key market players and what are their strategies in the Osteosarcoma Market?
What are the key market trends impacting the growth of the global Osteosarcoma Market?
What trends, challenges and barriers are influencing its growth?
What are the Osteosarcoma Market opportunities and threats faced by the vendors in the Osteosarcoma Market?
What are the key outcomes of the five forces analysis of The Osteosarcoma Market?
Research objectives of this report are:
To study and analyze the global Osteosarcoma (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Osteosarcoma market by identifying its various subsegments.
Focuses on the key global Osteosarcoma manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Osteosarcoma with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Osteosarcoma submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Browse Full Report @:
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687